Fasciola hepatica: The therapeutic potential of a worm secretome

International Journal for Parasitology

Volumn 43, Issue 3-4, 2013, Pages 283-291

  Robinson, Mark W ^a   Dalton, John P ^b   O'Brien, Bronwyn A ^c   Donnelly, Sheila ^d  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Cysteine protease; Diabetes; Fasciola hepatica; Helminth defence molecule; Macrophage; Peroxiredoxin

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CATHEPSIN L; CATHEPSIN L1; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 10; PEROXIREDOXIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

CELL ORGANELLE; DIABETES; DISEASE CONTROL; DISEASE TREATMENT; ENZYME ACTIVITY; IMMUNE RESPONSE; PARASITE; PHENOTYPE;

ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; CELL INTERACTION; CYTOKINE PRODUCTION; FASCIOLA HEPATICA; GRAFT REJECTION; HELMINTH; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; MACROPHAGE ACTIVATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; REVIEW; SEPTIC SHOCK; TH1 CELL; TH2 CELL; THERAPY WITH HELMINTHS;

FASCIOLA HEPATICA; TREMATODA; VERMES;

EID: 84873713953     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2012.11.004     Document Type: Review

References (100)

1. Abston E.D., Coronado M.J., Bucek A., Bedja D., Shin J., Kim J.B., Kim E., Gabrielson K.L., Georgakopoulos D., Mitzner W., Fairweather D. Th2 regulation of viral myocarditis in mice: different roles for TLR3 versus TRIF in progression to chronic disease. Clin. Dev. Immunol. 2012, 10.1155/2012/129486.
2. Agerberth B., Gunne H., Odeberg J., Kogner P., Boman H.G., Gudmundsson G.H. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:195-199.
3. Aitken M.M., Hughes D.L., Jones P.W., Hall G.A., Smith G.S. Immunological responses of fluke-infected and fluke-free cattle to Salmonella dublin and other antigens. Res. Vet. Sci. 1979, 27:306-312.
4. Allen J.E., Maizels R.M. Diversity and dialogue in immunity to helminths. Nat. Rev. Immunol. 2011, 11:375-388.
5. Andrews S.J. The life-cycle of Fasciola hepatica. Fasciolosis CAB International 1999, 1-29. Oxford. J.P. Dalton (Ed.).
6. Barnes K.C., Grant A.V., Gao P. A review of the genetic epidemiology of resistance to parasitic disease and atopic asthma: common variants for common phenotypes?. Curr. Opin. Allergy Clin. Immunol. 2005, 5:379-385.
7. Barrett J. Peroxide metabolism in the liver fluke. J. Parasitol. 1980, 66:697-701.
8. Berasaín P., Goñi F., McGonigle S., Dowd A., Dalton J.P., Frangione B., Carmona C. Proteinases secreted by Fasciola hepatica degrade extracellular matrix and basement membrane components. J. Parasitol. 1997, 83:1-5.
9. Bilbo S.D., Wray G.A., Perkins S.E., Parker W. Reconstitution of the human biome as the most reasonable solution for epidemics of allergic and autoimmune diseases. Med. Hypotheses 2011, 77:494-504.
10. Boman H.G. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 1995, 13:61-92.
11. Brady M.T., O'Neill S.M., Dalton J.P., Mills K.H. Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis. Infect. Immun. 1999, 67:5372-5378.
12. Brown W.C., Davis W.C., Dobbelaere D.A.E., Rice-Ficht A.C. CD4+ T-cell clones obtained from cattle chronically infected with Fasciola hepatica and specific for adult worm antigen express both unrestricted and Th2 cytokine profiles. Infect. Immun. 1994, 62:818-827.
13. Callahan H.L., Crouch R.K., James E.R. Helminth anti-oxidant enzymes - a protective mechanism against host oxidants. Parasitol. Today 1988, 4:218-225.
14. Chua K.Y., Stewart G.A., Thomas W.R., Simpson R.J., Dilworth R.J., Plozza T.M., Turner K.J. Sequence analysis of cDNA coding for a major house dust mite allergen, Der p 1. Homology with cysteine proteases. J. Exp. Med. 1988, 167:175-182.
15. Claridge J., Diggle P., McCann C.M., Mulcahy G., Flynn R., McNair J., Strain S., Welsh M., Baylis M., Williams D.J. Fasciola hepatica is associated with the failure to detect bovine tuberculosis in dairy cattle. Nat. Commun. 2012, 3:853.
16. Clery D., Torgerson P., Mulcahy G. Immune responses of chronically infected adult cattle to Fasciola hepatica. Vet. Parasitol. 1996, 62:71-82.
17. Cocks T.M., Moffatt J.D. Protease-activated receptors: sentries for inflammation?. Trends Pharmacol. Sci. 2000, 21:103-108.
18. Collins P.R., Stack C.M., O'Neill S.M., Doyle S., Ryan T., Brennan G.P., Mousley A., Stewart M., Maule A.G., Dalton J.P., Donnelly S. Cathepsin L1, the major protease involved in liver fluke (Fasciola hepatica) virulence: propetide cleavage sites and autoactivation of the zymogen secreted from gastrodermal cells. J. Biol. Chem. 2004, 279:17038-17042.
19. Cooke A., Tonks P., Jones F.M., O'Shea H., Hutchings P., Fulford A.J., Dunne D.W. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 1999, 21:169-176.
20. Cornell R.B., Taneva S.G. Amphipathic helices as mediators of the membrane interaction of amphitropic proteins, and as modulators of bilayer physical properties. Curr. Protein Pept. Sci. 2006, 2006(7):539-552.
21. Correale J., Farez M. Association between parasite infection and immune responses in multiple sclerosis. Ann. Neurol. 2007, 61:97-108.
22. Dalton J.P., Heffernan M. Thiol proteases released in vitro by Fasciola hepatica. Mol. Biochem. Parasitol. 1989, 35:161-166.
23. De Groot A.S., McMurry J., Moise L. Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates. Curr. Opin. Pharmacol. 2008, 8:620-626.
24. Donnelly S., O'Neill S.M., Sekiya M., Mulcahy G., Dalton J.P. Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages. Infect. Immun. 2005, 73:166-173.
25. Donnelly S., Stack C.M., O'Neill S.M., Sayed A.A., Williams D.L., Dalton J.P. Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages. FASEB J. 2008, 22:4022-4032.
26. Donnelly S., O'Neill S.M., Stack C.M., Robinson M.W., Turnbull L., Whitchurch C., Dalton J.P. Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3. J. Biol. Chem. 2010, 285:3383-3392.
27. Dowling D.J., Hamilton C.M., Donnelly S., La Course J., Brophy P.M., Dalton J., O'Neill S.M. Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses. Infect. Immun. 2010, 78:793-801.
28. Fais S., De Milito A., You H., Qin W. Targeting vacuolar H+-ATPases as a new strategy against cancer. Cancer Res. 2007, 67:10627-10630.
29. Farid A.S., Jimi F., Inagaki-Ohara K., Horii Y. Increased intestinal endotoxin absorption during enteric nematode but not protozoal infections through a mast cell-mediated mechanism. Shock 2008, 29:709-716.
30. Fleming J.O., Cook T.D. Multiple sclerosis and the hygiene hypothesis. Neurology 2006, 67:2085-2086.
31. Flynn R.J., Mannion C., Golden O., Hacariz O., Mulcahy G. Experimental Fasciola hepatica infection alters responses to tests used for diagnosis of bovine tuberculosis. Infect. Immun. 2007, 75:1373-1381.
32. Flynn R.J., Mulcahy G. The roles of IL-10 and TGF-beta in controlling IL-4 and IFN-gamma production during experimental Fasciola hepatica infection. Int. J. Parasitol. 2008, 38:1673-1680.
33. Flynn R.J., Mulcahy G., Welsh M., Cassidy J.P., Corbett D., Milligan C., Andersen P., Strain S., McNair J. Co-infection of cattle with Fasciola hepatica and Mycobacterium bovis- immunological consequences. Transbound. Emerg. Dis. 2009, 56:269-274.
34. Frantz F.G., Rosada R.S., Peres-Buzalaf C., Perusso F.R., Rodrigues V., Ramos S.G., Kunkel S.L., Silva C.L., Faccioli L.H. Helminth coinfection does not affect therapeutic effect of a DNA vaccine in mice harboring tuberculosis. PLoS Negl. Trop. Dis. 2010, 4:e700.
35. Frasca L., Lande R. Role of defensins and cathelicidin LL37 in auto-immune and auto- inflammatory diseases. Curr. Pharm. Biotechnol. 2012, 13:1882-1897.
36. Fumagalli M., Pozzoli U., Cagliani R., Comi G.P., Riva S., Clerici M., Bresolin N., Sironi M. Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. J. Exp. Med. 2009, 206:1395-1408.
37. Furuta T., Imajo-Ohmi S., Fukuda H., Kano S., Miyake K., Watanabe N. Mast cell-mediated immune responses through IgE antibody and Toll-like receptor 4 by malarial peroxiredoxin. Eur. J. Immunol. 2008, 38:1341-1350.
38. Gale E.A. A missing link in the hygiene hypothesis?. Diabetologia 2002, 45:588-594.
39. Garcia H.H., Moro P.L., Schantz P.M. Zoonotic helminth infections of humans: echinococcosis, cysticercosis and fascioliasis. Curr. Opin. Infect. Dis. 2007, 20:489-494.
40. Giuliani A., Pirri G., Rinaldi A.C. Antimicrobial peptides: the LPS connection. Methods Mol. Biol. 2010, 618:137-154.
41. Golden O., Flynn R.J., Read C., Sekiya M., Donnelly S.M., Stack C., Dalton J.P., Mulcahy G. Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1). Vaccine 2010, 28:5551-5557.
42. Gottar M., Gobert V., Matskevich A.A., Reichhart J.M., Wang C., Butt T.M., Belvin M., Hoffmann J.A., Ferrandon D. Dual detection of fungal infections in Drosophila via recognition of glucans and sensing of virulence factors. Cell 2006, 127:1425-1437.
43. Grobe K., Becker W.M., Schlaak M., Petersen A. Grass group I allergens (β-expansins) are novel, papain-related proteinases. Eur. J. Biochem. 1999, 263:33-40.
44. Grogan J.L., Kremsner P.G., Deelder A.M., Yazdanbakhsh M. Elevated proliferation and interleukin-4 release from CD4+ cells after chemotherapy in human Schistosoma haematobium infection. Eur. J. Immunol. 1996, 26:1365-1370.
45. Gudmundsson G.H., Agerberth B., Odeberg J., Bergman T., Olsson B., Salcedo R. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 1996, 238:325-332.
46. Harnett W., Harnett M.M. Helminth-derived immunomodulators: can understanding the worm produce the pill?. Nat. Rev. Immunol. 2010, 10:278-284.
47. Hazlett L., Wu M. Defensins in innate immunity. Cell Tissue Res. 2010, 343:175-188.
48. Jackson J.A., Friberg I.M., Little S., Bradley J.E. Review series on helminths, immune modulation and the hygiene hypothesis: immunity against helminths and immunological phenomena in modern human populations: coevolutionary legacies?. Immunology 2009, 126:18-27.
49. Joshi A.D., Schaller M.A., Lukacs N.W., Kunkel S.L., Hogaboam C.M. TLR3 modulates immunopathology during a Schistosoma mansoni egg-driven Th2 response in the lung. Eur. J. Immunol. 2008, 38:3436-3449.
50. Kartner N., Yao Y., Li K., Crasto G.J., Datti A., Manolson M.F. Inhibition of osteoclast bone resorption by disrupting vacuolar H+-ATPase a3-b2 subunit interaction. J. Biol. Chem. 2010, 285:37476-37490.
51. Kouzaki H., O'Grady S.M., Lawrence C.B., Kita H. Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J. Immunol. 2009, 183:1427-1434.
52. La Flamme A.C., Ruddenklau K., Bäckström B.T. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect. Immun. 2003, 71:4996-5004.
53. Maizels R.M. Parasite immunomodulation and polymorphisms of the immune system. J. Biol. 2009, 8:62-65.
54. Matsumura Y. Role of allergen source-derived proteases in sensitization via airway epithelial cells. J. Allergy 2012, 2012:903659.
55. McDermott J.R., Bartram R.E., Knight P.A., Miller H.R., Garrod D.R., Grencis R.K. Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:7761-7766.
56. McGonigle S., Dalton J.P. Isolation of Fasciola hepatica haemoglobin. Parasitology 1995, 111:209-215.
57. McGonigle S., Dalton J.P., James E.R. Peroxidoxins: a new antioxidant family. Parasitol. Today 1998, 14:139-145.
58. McSorley H.J., Maizels R.M. Helminth infections and host immune regulation. Clin. Microbiol. Rev. 2012, 25:585-608.
59. Miller C.M., Smith N.C., Ikin R.J., Boulter N.R., Dalton J.P., Donnelly S. Immunological interactions between 2 common pathogens, Th1-inducing protozoan Toxoplasma gondii and the Th2-inducing helminth Fasciola hepatica. PLoS ONE 2009, 4:e5692.
60. Mills E.N., Jenkins J.A., Alcocer M.J., Shewry P.R. Structural, biological, and evolutionary relationships of plant food allergens sensitizing via the gastrointestinal tract. Crit. Rev. Food Sci. Nutr. 2004, 44:379-407.
61. Melon A., Wang A., Phan V., McKay D.M. Infection with Hymenolepis diminuta is more effective than daily corticosteroids in blocking chemically induced colitis in mice. J. Biomed. Biotechnol. 2010, 2010:384523.
62. Mikita J., Dubourdieu-Cassagno N., Deloire M.S., Vekris A., Biran M., Raffard G., Brochet B., Canron M.H., Franconi J.M., Boiziau C., Petry K.G. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration: clinical and laboratory research. Mult. Scler. 2011, 17:2-15.
63. Moller M., Gravenor M.B., Roberts S.E., Sun D., Gao P., Hopkin J.M. Genetic haplotypes of Th-2 immune signalling link allergy to enhanced protection to parasitic worms. Hum. Mol. Genet. 2007, 16:1828-1836.
64. Mulcahy G., O'Connor F., McGonigle S., Dowd A., Clery D.G., Andrews S.J., Dalton J.P. Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica. Vaccine 1998, 16:932-939.
65. Mulcahy G., O'Connor F., Clery D., Hogan S.F., Dowd A.J., Andrews S.J., Dalton J.P. Immune responses of cattle to experimental anti-Fasciola hepatica vaccines. Res. Vet. Sci. 1999, 67:27-33.
66. Mylonas K.J., Nair M.G., Prieto-Lafuente L., Paape D., Allen J.E. Alternatively activated macrophages elicited by helminth infection can be reprogrammed to enable microbial killing. J. Immunol. 2009, 182:3084-3094.
67. Nagaoka I., Hirota S., Niyonsaba F., Hirata M., Adachi Y., Tamura H., Heumann D. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-a by blocking the binding of LPS to CD14+ cells. J. Immunol. 2001, 167:3329-3338.
68. O'Neill S.M., Parkinson M., Strauss W., Angles R., Dalton J.P. Immunodiagnosis of Fasciola hepatica infection (fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase. Am. J. Trop. Med. Hyg. 1998, 58:417-423.
69. O'Neill S.M., Mills K.H., Dalton J.P. Fasciola hepatica cathepsin L cysteine proteinase suppresses Bordetella pertussis-specific interferon-gamma production in vivo. Parasite Immunol. 2001, 23:541-547.
70. Onguru D., Liang Y., Griffith Q., Nikolajczyk B., Mwinzi P., Ganley-Leal L. Human schistosomiasis is associated with endotoxemia and toll-like receptor 2- and 4- bearing B cells. Am. J. Trop. Med. Hyg. 2011, 84:321-324.
71. Parsa, R., Andresen, P., Gillett, A., Mia, S., Zhang, X.M., Mayans, S., Holmberg, D., Harris, R.A., 2012. Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice. Diabetes (Epub ahead of print).
72. Pisal D.S., Kosloski M.P., Middaugh C.R., Bankert R.B., Balu-iyer S.V. Native-like aggregates of factor VIII are immunogenic in von Willebrand factor deficient and hemophilia a mice. J. Pharm. Sci. 2012, 101:2055-2065.
73. Porcelli F., Verardi R., Shi L., Henzler-Wildman K.A., Ramamoorthy A., Veglia G. NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles. Biochemistry 2008, 47:5565-5572.
74. Pritchard D. Worm therapy: for or against?. J. Helminthol. 2011, 85:225-227.
75. Pritchard D. Worm therapy: how would you like your medicine?. Int. J. Parasitol. 2012, 2:106-108.
76. Riddell J.R., Wang X.Y., Minderman H., Gollnick S.O. Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4. J. Immunol. 2010, 184:1022-1030.
77. Rook G.A. Hygiene hypothesis and autoimmune diseases. Clin. Rev. Allergy Immunol. 2012, 42:5-15.
78. Robinson M.W., Dalton J.P., Donnelly S. Helminth pathogen cathepsin proteases: it's a family affair. Trends Biochem. Sci. 2008, 33:601-608.
79. Robinson M.W., Menon R., Donnelly S.M., Dalton J.P., Ranganathan S. An integrated transcriptomic and proteomic analysis of the secretome of the helminth pathogen, Fasciola hepatica: proteins associated with invasion and infection of the mammalian host. Mol. Cell. Proteomics 2009, 8:1891-1907.
80. Robinson M.W., Dalton J.P. Zoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases Phil. Trans. R. Soc. B 2009, 364:2763-2776.
81. Robinson M.W., Donnelly S., Hutchinson A.T., To J., Taylor N.L., Norton R.S., Perugini M.A., Dalton J.P. A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides. PLoS Pathog. 2011, 7:e1002042.
82. Robinson, M.W., Alvarado, R., To, J., Hutchinson, A.T., Dowdell, S.N., Lund, M., Turnbull, L., Whitchurch, C.B., O'Brien, B.A., Dalton, J.P., Donnelly, S., 2012. A helminth cathelicidin-like protein suppresses antigen processing and presentation in macrophages via inhibition of lysosomal vATPase. FASEB J. (Epub ahead of print).
83. Sajid M., McKerrow J.H. Cysteine proteases of parasitic organisms. Mol. Biochem. Parasitol. 2002, 120:1-21.
84. Sandgren S., Wittrup A., Cheng F., Jonsson M., Eklund E., Busch S., Belting M. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J. Biol. Chem. 2004, 279:17951-17956.
85. Sartono E., Kruize Y.C., Kurniawan A., van der Meide P.H., Partono F., Maizels R.M., Yazdanbakhsh M. Elevated cellular immune responses and interferon-gamma release after long-term diethylcarbamazine treatment of patients with human lymphatic filariasis. J. Infect. Dis. 1995, 171:1683-1687.
86. Scott M.G., Hancock R.E. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit. Rev. Immunol. 2000, 20:407-431.
87. Shichita T., Hasegawa E., Kimura A., Morita R., Sakaguchi R., Takada I., Sekiya T., Ooboshi H., Kitazono T., Yanagawa T., Ishii T., Takahashi H., Mori S., Nishibori M., Kuroda K., Akira S., Miyake K., Yoshimura A. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat. Med. 2012, 18:911-917.
88. Smith A.M., Dowd A.J., McGonigle S., Keegan P.S., Brennan G., Trudgett A., Dalton J.P. Purification of a cathepsin L-like proteinase secreted by adult Fasciola hepatica. Mol. Biochem. Parasitol. 1993, 62:1-8.
89. Stas P., Lasters I. Strategies for preclinical immunogenicity assessment of protein therapeutics. IDrugs 2009, 3:169-173.
90. Summers R.W., Elliott D.E., Urban J.F., Thompson R., Weinstock J.V. Trichuris suis therapy in Crohn's disease. Gut 2005, 54:87-90.
91. Summers R.W., Elliott D.E., Urban J.F., Thompson R.A., Weinstock J.V. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005, 128:825-832.
92. Tang W.C., Kasturi S.P., Ravindran R., Nakaya H.I., Kundu K., Murthy N., Kepler T.B., Malissen B., Pulendran B. The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signalling. Nat. Immunol. 2010, 11:608-617.
93. Tort J., Brindley P.J., Knox D., Wolfe K.H., Dalton J.P. Proteinases and associated genes of parasitic helminths. Adv. Parasitol. 1999, 43:161-266.
94. Walsh K.P., Brady M.T., Finlay C.M., Boon L., Mills K.H. Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J. Immunol. 2009, 183:1577-1586.
95. West R.L., Zelinkova Z., Wolbink G.J., Kuipers E.J., Stokkers P.C., van der Woude C.J. Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn's disease. Aliment. Pharmacol. Ther. 2008, 28:1122-1126.
96. Wilson M.S., Mentink-Kane M.M., Pesce J.T., Ramalingam T.R., Thompson R., Wynn T.A. Immunopathology of schistosomiasis. Immunol. Cell Biol. 2007, 85:148-154.
97. Yang D., Chertov O., Oppenheim J.J. The role of mammalian antimicrobial peptides and proteins in awakening of innate host defences and adaptive immunity. Cell. Mol. Life Sci. 2001, 58:978-989.
98. Yang D., Chertov O., Oppenheim J.J. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J. Leukoc. Biol. 2001, 69:691-697.
99. Yang D., Biragyn A., Kwak L.W., Oppenheim J.J. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 2002, 23:291-296.
100. Zaccone P., Fehervari Z., Phillips J.M., Dunne D.W., Cooke A. Parasitic worms and inflammatory diseases. Parasite Immunol. 2006, 28:515-523.